Cosmo Bio Company,Limited

Tokyo Stock Exchange 3386.T

Cosmo Bio Company,Limited Cash and Short-Term Investments for the year ending December 31, 2023: USD 21.44 M

Cosmo Bio Company,Limited Cash and Short-Term Investments is USD 21.44 M for the year ending December 31, 2023, a -7.38% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • Cosmo Bio Company,Limited Cash and Short-Term Investments for the year ending December 31, 2022 was USD 23.15 M, a -25.04% change year over year.
  • Cosmo Bio Company,Limited Cash and Short-Term Investments for the year ending December 31, 2021 was USD 30.88 M, a -2.09% change year over year.
  • Cosmo Bio Company,Limited Cash and Short-Term Investments for the year ending December 31, 2020 was USD 31.54 M, a 3,327.97% change year over year.
  • Cosmo Bio Company,Limited Cash and Short-Term Investments for the year ending December 31, 2019 was USD 920.00 K.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 3386.T

Cosmo Bio Company,Limited

CEO Norihiko Shibayama
IPO Date Sept. 27, 2005
Location Japan
Headquarters Toyo-Ekimae Building
Employees 155
Sector Health Care
Industries
Description

Cosmo Bio Company,Limited engages in the import, export, manufacture, marketing, and sale of life science research biotools. Its life science research tools include reagents, kits, instruments, software, and diagnostics products. The company offers research reagents, such as antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, bacteria, and others, as well as offers detection reagents, cell and tissue culture systems, gene analysis systems, and others. It also provides research instruments comprising electrophoresis apparatuses, cell culture labware, gene manipulation systems, data analysis software, and others; drug discovery and custom research services; and clinical diagnostics. In addition, the company develops and manufactures cell/cell culture products, including adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem, and feeder cells, as well as tumor cell lines, coating reagents, macrophage-related products, etc.; and assay kit related products that comprise various measurement kits, staining kits, detection/purification kits, etc. Further, it offers biotechnology research equipment, which include constant-temperature transport containers, aluminum block mat heat insulation devices, dew condensation prevention glass plates, etc.; and consigned, custom peptide synthesis, and antibody production services. The company serves laboratories, research institutes, and life-science education and testing organizations. It sells its products through outlets in Japan, as well as a network of sales agents internationally. Cosmo Bio Company,Limited was founded in 1978 and is headquartered in Tokyo, Japan.

StockViz Staff

January 31, 2025

Any question? Send us an email